Liposomal Bupivacaine in Total Knee Arthroplasty

Withdrawn before enrolling · Phase 4

Conditions studied: Pain, Postoperative, Arthroplasty, Replacement, Knee, Osteoarthritis

In brief

Liposomal bupivacaine is a novel local anesthetic designed for prolonged pain relief. Despite its long-acting analgesic potential, liposomal bupivacaine is significantly more expensive than other local anesthetic alternatives. The primary aim of this investigation is to examine whether or not liposomal bupivacaine provides superior pain relief or clinically significant opioid-sparing effects versus a control to justify its cost.

Key facts

Study ID

NCT02426164

Run by

Miller Orthopedic Specialists

People needed

0

Starts

2015-06-01

Expected to finish

2017-06-01

Last updated by the study team

2016-03-22

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients undergoing a primary unilateral total knee arthroplasty by the PI of the trial

You may not qualify if…

• Patients with a sensitivity to marcaine
• Pregnant or lactating women
• Non-English speaking individuals

Where it is running

• Miller Orthopedic Specialists — Council Bluffs, Iowa, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.